Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

Beurer BM75 85 blood pressure meterSeptember 1 2015

Beurer has extended it blood pressure monitor range with two slimline versions which can upload results wirelessly.

Readings from the BM 75 can be uploaded to a smartphone running Beurer’s HealthManager app using NFC (near field communication) to transmit results over a few centimetres, or via a USB cable to a PC running the HealthManager desktop suite on a PC. The BM 85 uses Bluetooth to transfer data wirelessly over greater distances.

The BM 75 and BM 85 each feature “a large backlit LCD that displays pulse, systolic and diastolic readings with a patented resting indicator for exact measurement results and hemodynamic stability diagnosis.” Readings are displayed to show whether they lie within WHO guidelines and the monitors also include an arrhythmia detection function.

HealthManager is a free app that “combines four key aspects of health management and alongside blood pressure can help users manage fitness and sleep, weight and body composition and blood glucose for a complete analysis of their state of health, fitness and wellbeing.”

Robert Slade, Managing Director for Beurer UK said: “As well as delivering a slimline, compact device that’s extremely fast and easy to use, the ability to wirelessly upload results and view blood pressure history through HealthManager is a great example of how modern technology can work together to provide genuine advantages to our day to day lives”.

The blood pressure monitors are available from Boots and Argos, and retail at £74.99 for the BM 75 and £99.99 for the BM 85.



July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...